Davidoff AM - Search Results

1

MicroRNA-204 increases sensitivity of neuroblastoma cells to cisplatin and is associated with a favourable clinical outcome.

Ryan J, Tivnan A, Fay J, Bryan K, Meehan M, Creevey L, Lynch J, Bray IM, O'Meara A, Tracey L, Davidoff AM, Stallings RL. Ryan J, et al. Among authors: davidoff am. Br J Cancer. 2012 Sep 4;107(6):967-76. doi: 10.1038/bjc.2012.356. Epub 2012 Aug 14. Br J Cancer. 2012. PMID: 22892391 Free PMC article.

2

IFN-beta sensitizes neuroblastoma to the antitumor activity of temozolomide by modulating O6-methylguanine DNA methyltransferase expression.

Rosati SF, Williams RF, Nunnally LC, McGee MC, Sims TL, Tracey L, Zhou J, Fan M, Ng CY, Nathwani AC, Stewart CF, Pfeffer LM, Davidoff AM. Rosati SF, et al. Among authors: davidoff am. Mol Cancer Ther. 2008 Dec;7(12):3852-8. doi: 10.1158/1535-7163.MCT-08-0806. Epub 2008 Dec 3. Mol Cancer Ther. 2008. PMID: 19056675 Free PMC article.

3

NF-kappaB activation mediates resistance to IFN beta in MLL-rearranged acute lymphoblastic leukemia.

Tracey L, Streck CJ, Du Z, Williams RF, Pfeffer LM, Nathwani AC, Davidoff AM. Tracey L, et al. Among authors: davidoff am. Leukemia. 2010 Apr;24(4):806-12. doi: 10.1038/leu.2010.2. Epub 2010 Feb 4. Leukemia. 2010. PMID: 20130599 Free PMC article.

4

MicroRNA-184-mediated inhibition of tumour growth in an orthotopic murine model of neuroblastoma.

Tivnan A, Foley NH, Tracey L, Davidoff AM, Stallings RL. Tivnan A, et al. Among authors: davidoff am. Anticancer Res. 2010 Nov;30(11):4391-5. Anticancer Res. 2010. PMID: 21115884 Free PMC article.

5

MicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastoma.

Tivnan A, Tracey L, Buckley PG, Alcock LC, Davidoff AM, Stallings RL. Tivnan A, et al. Among authors: davidoff am. BMC Cancer. 2011 Jan 25;11:33. doi: 10.1186/1471-2407-11-33. BMC Cancer. 2011. PMID: 21266077 Free PMC article.

6

MicroRNA-542-5p as a novel tumor suppressor in neuroblastoma.

Bray I, Tivnan A, Bryan K, Foley NH, Watters KM, Tracey L, Davidoff AM, Stallings RL. Bray I, et al. Among authors: davidoff am. Cancer Lett. 2011 Apr 1;303(1):56-64. doi: 10.1016/j.canlet.2011.01.016. Cancer Lett. 2011. PMID: 21310526 Free PMC article.

7

Assessing interactions for fixed-dose drug combinations in tumor xenograft studies.

Wu J, Tracey L, Davidoff AM. Wu J, et al. Among authors: davidoff am. J Biopharm Stat. 2012;22(3):535-43. doi: 10.1080/10543406.2011.556285. J Biopharm Stat. 2012. PMID: 22416839 Free PMC article.

8

Inhibition of neuroblastoma tumor growth by targeted delivery of microRNA-34a using anti-disialoganglioside GD2 coated nanoparticles.

Tivnan A, Orr WS, Gubala V, Nooney R, Williams DE, McDonagh C, Prenter S, Harvey H, Domingo-Fernández R, Bray IM, Piskareva O, Ng CY, Lode HN, Davidoff AM, Stallings RL. Tivnan A, et al. Among authors: davidoff am. PLoS One. 2012;7(5):e38129. doi: 10.1371/journal.pone.0038129. Epub 2012 May 25. PLoS One. 2012. PMID: 22662276 Free PMC article.

9

IFN-beta restricts tumor growth and sensitizes alveolar rhabdomyosarcoma to ionizing radiation.

Sims TL, McGee M, Williams RF, Myers AL, Tracey L, Hamner JB, Ng C, Wu J, Gaber MW, McCarville B, Nathwani AC, Davidoff AM. Sims TL, et al. Among authors: davidoff am. Mol Cancer Ther. 2010 Mar;9(3):761-71. doi: 10.1158/1535-7163.MCT-09-0800. Epub 2010 Mar 2. Mol Cancer Ther. 2010. PMID: 20197402

10

Maturation of tumor vasculature by interferon-beta disrupts the vascular niche of glioma stem cells.

Williams RF, Sims TL, Tracey L, Myers AL, Ng CY, Poppleton H, Nathwani AC, Davidoff AM. Williams RF, et al. Among authors: davidoff am. Anticancer Res. 2010 Sep;30(9):3301-8. Anticancer Res. 2010. PMID: 20944101

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

366 results

Search Page